BD’s 65-Year Manufacturing Legacy in Nebraska Powers U.S. Healthcare Innovation


Re-Tweet
Share on LinkedIn

BD’s 65-Year Manufacturing Legacy in Nebraska Powers U.S. Healthcare Innovation

Billions of Medical Devices Produced Annually in Broken Bow Underscore Global Impact

BD (Becton, Dickinson and Company) is marking a significant milestone—65 years of continuous operations and innovation at its Broken Bow, Nebraska facility. What started in 1960 as a 13,753-square-foot steel building with just 20 associates has grown into a 310,000-square-foot plant employing nearly 600 people today. Broken Bow stands as the world’s largest manufacturer of BD Vacutainer® tubes, supplying billions of essential devices every year. These products, used across millions of patient care settings globally, help drive high-quality specimen collection, patient comfort, and health care provider safety.

BD’s Ongoing Investments Cement Nebraska as a U.S. MedTech Manufacturing Hub

BD’s Nebraska presence is more than legacy—it’s about building the future. The company has invested over $50 million since 2020 in its Broken Bow site to expand and modernize operations, including cutting-edge chemistry lab upgrades. Statewide, BD remains the largest manufacturer with four facilities and about 2,700 associates. Notably, more than $35 million and 50 new jobs have been dedicated to growing syringe production in Columbus, further reinforcing U.S. healthcare resiliency and supply chain stability.

Nebraska Sites BD Investment (since 2020) Associates Key Production Focus
Broken Bow $50M+ ~600 BD Vacutainer® tubes, specimen collection, urine collection devices
Columbus $35M+ (latest) N/A Prefilled flush syringes, supply chain resiliency
All Nebraska Sites $85M+ (recent) ~2,700 Medical device manufacturing

Long-Term Commitment to Local Community and Healthcare Education

Celebrating 65 years in Broken Bow, BD isn’t just recognizing technological milestones but also decades of local impact. The facility’s anniversary brought together leaders, local officials, and associates—honoring several with 25 to over 40 years of service. BD’s support for Custer County Foundation, including $6,500 in new scholarships and $40,000 contributed over the past five years, shows sustained commitment to advancing youth education, healthcare careers, and STEM opportunities in the region. Collaboration with Mid-Plains Community College helps further strengthen pathways into MedTech manufacturing for local graduates.

Strengthening the U.S. Healthcare System: Scale, Supply, and Innovation

As one of the largest global MedTech manufacturers, BD operates over 30 facilities in the U.S., employing more than 10,000 people and providing the backbone for reliable medical device supply. In addition to its Nebraska footprint, BD recently celebrated 55 years at its Sumter, S.C. site, underscoring its ongoing strategy of local manufacturing, innovation, and community support. BD’s reach in the specimen management market is substantial: since 2018, BD Vacutainer® tubes have been cited in more than 16,000 clinical studies, directly advancing diagnostic quality and care.

Key Takeaway: A Model for Sustainable Manufacturing and Community Impact

For investors, community members, and healthcare professionals alike, BD’s Broken Bow facility represents more than just manufacturing scale. It’s an evolving case study in operational longevity, reinvestment, and positive regional impact—all while ensuring resilient healthcare supply chains. With strategic upgrades and ongoing partnerships in Nebraska, BD’s commitment appears well-positioned to sustain both innovation and community growth for years to come.

Contact Information

Media Investors
Fallon McLoughlan
BD Public Relations
201.258.0361
Fallon.McLoughlin@bd.com
Adam Reiffe
Vice President, Investor Relations
201.847.6927
adam.reiffe@bd.com

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.


About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.


NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.


The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.


Disclosure: This article was generated with the assistance of AI

Market Data Delayed 15 Minutes